JGP Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
JGP Wealth Management's BMY Position: Q3 2022 in Review
JGP Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 2,690 shares — an estimated $205K sold.
JGP Wealth Management first reported a position in BMY in Q1 2022 and held it in 2 quarters. The position peaked at $208K in Q1 2022. 2,470 funds tracked by Wall St. Rank hold BMY as of Q3 2022.
- JGP Wealth Management reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
- JGP Wealth Management sold 2,690 Bristol-Myers Squibb shares in Q3 2022, an estimated $205K.
- JGP Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2022 and held it in 2 quarters.
- JGP Wealth Management's Bristol-Myers Squibb position peaked at $208K in Q1 2022.
- 2,470 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.
Based on JGP Wealth Management's 13F filing for Q3 2022, filed 14 Oct 2022.